Assyro AI

FDA Orange Book · active-ingredient family

Thiothixene hydrochloride

Thiothixene hydrochloride is approved as 2 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NAVANE · NDA 016758

2

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · concentrate, injectable

ProductApplicantApplicationTEApproved
NAVANERLDPFIZERNDA 016758Approved Prior to Jan 1, 1982
NAVANE×2PFIZERNDA 016904Approved Prior to Jan 1, 1982

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
THIOTHIXENE HYDROCHLORIDE INTENSOLHIKMAANDA 073494Jun 30, 1992
THIOTHIXENE HYDROCHLORIDEPACOANDA 071917Sep 20, 1989
THIOTHIXENE HYDROCHLORIDEPACOANDA 071939Dec 16, 1988
THIOTHIXENE HYDROCHLORIDEALPHARMA US PHARMSANDA 070969Oct 16, 1987
THIOTHIXENE HYDROCHLORIDETEVA PHARMSANDA 071554Oct 16, 1987
THIOTHIXENE HYDROCHLORIDETEVAANDA 071184Jun 22, 1987

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Thiothixene hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.